Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy. [PDF]
Atay İ, Eröz E, Heybeli C.
europepmc +1 more source
A membranous nephropathy variant mimicking minimal change disease. [PDF]
Pan C +8 more
europepmc +1 more source
Obinutuzumab in the treatment of idiopathic refractory membranous nephropathy: an observational case series. [PDF]
Zhao X +8 more
europepmc +1 more source
The PLA2R Paradox: Seropositive Membranous Nephropathy With Negative Staining. [PDF]
Tang X +6 more
europepmc +1 more source
Durvalumab-associated membranous nephropathy: a case report and brief literature review. [PDF]
Mizoguchi R, Tashiro T, Sakakima M.
europepmc +1 more source
Thromboembolism in the left main coronary artery of a patient with membranous nephropathy: a case report. [PDF]
Wang B, Lu M, Zhang H, Huang C, Zhang W.
europepmc +1 more source
INPP5D/SHIP1-mediated immunometabolic remodeling of renal monocytes in idiopathic membranous nephropathy. [PDF]
Dai H +6 more
europepmc +1 more source
Autophagy in the Pathogenesis of Membranous Nephropathy. [PDF]
Ponticelli C, Reggiani F, Moroni G.
europepmc +1 more source
Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. [PDF]
Madan A +16 more
europepmc +1 more source

